Lysosomal Therapeutics lysosomaltx.com


Public list: BIO 2016 (619) Pharma Startups (4733)

Lysosomal Therapeutics (LTI) is dedicated to small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases. The company's strategy leverages the clinically-validated link between lysosome-based genetic disorders and neurodegenerative diseases to establish a unique and effective molecular platform for novel drug discovery. LTI's lead program targets Gaucher-related neurodegeneration, Parkinson's disease and...Show all

Lysosomal Therapeutics (LTI) is dedicated to small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases. The company's strategy leverages the clinically-val...Show all

Company (Alive / Active)

Phone: 617-913-0166

Fax:

19 Blackstone Street

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lysosomal Therapeutics $36.9M Jan 10, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lysosomal Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors
There is no Competitors data available for this company. Please select another tab.